1. Home
  2. FTLF vs AGEN Comparison

FTLF vs AGEN Comparison

Compare FTLF & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FitLife Brands Inc.

FTLF

FitLife Brands Inc.

HOLD

Current Price

$10.04

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.10

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTLF
AGEN
Founded
2005
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.1M
147.4M
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
FTLF
AGEN
Price
$10.04
$3.10
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$21.50
$14.50
AVG Volume (30 Days)
27.6K
800.2K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
100.00
EPS
0.17
1.02
Revenue
$21,744,000.00
$42,877,086.00
Revenue This Year
$45.76
$107.63
Revenue Next Year
$5.10
N/A
P/E Ratio
$60.76
$3.11
Revenue Growth
11.52
89.95
52 Week Low
$8.67
$2.71
52 Week High
$20.98
$7.34

Technical Indicators

Market Signals
Indicator
FTLF
AGEN
Relative Strength Index (RSI) 49.26 37.45
Support Level $8.79 $2.91
Resistance Level $15.34 $3.26
Average True Range (ATR) 0.83 0.26
MACD 0.17 -0.07
Stochastic Oscillator 45.88 5.99

Price Performance

Historical Comparison
FTLF
AGEN

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: